Dividend-News

Daily dividend news for investors in dividend stocks


Should Gilead Sciences Declare a Dividend?

Published Thu, 17 Jun 2010 10:30:54 -0400 on Seeking Alpha

Investors in Gilead Sciences (GILD) have had quite a run over the past decade. From 1996 through 2008, GILD shares posted gains every single year. During that same 13-year period, the Dow Jones index only posted gains in 8 years. The other 5 years the Dow posted some significant losses. Investors who purchased GILD shares at the beginning of 1996 have experienced a phenomenal 5,922% return. It seemed like the stock could only climb higher each year and the stock split four times from 2001-2006.... Read more

Stock name Last trade   P/E Earnings/Share Dividend/Share Dividend yield
GLAXOSMITHKLINE 39.93   21.6 1.85 2.38 5.99
GILEAD SCIENCES 62.80   15.1 4.16 2.52 4.07
BRISTOL-MYERS SQUIBB 44.62   14.7 3.03 1.64 3.63

GLAXOSMITHKLINE - GSK
GLAXOSMITHKLINE - GSK  


Older articles featuring Glaxosmithkline (GSK):
Parking Cash In The Large Cap 5% Dividend Club
Lanny's January Dividend Income Summary
5%+ Dividend Yield Portfolio: Profiting Handsomely From Volatility (Jan 2019 Review)
High Yield Stocks For Investors Looking For Income Options
5%+ Dividend Yield Portfolio: Beating The Market 2 Of The Last 3 Years (December 2018 Review)
5%+ Dividend Yield Portfolio: Profiting From A Return To Normal (October 2018 Review)
Healthcare Yields Of 3% To 4.8% From Top 10 WallStars In November
Bert's October Dividend Income Summary
5%+ Dividend Yield Portfolio: Playing Offense, Not Running Scared (October 2018 Review)
5%+ Dividend Yield Portfolio: Ignore The Political Circus (Sep 2018 Review)

More